TARA
Protara Therapeutics Inc
2.70$
-2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +0.0% | -22.4% | +0.0% | +1.2% | – | – | +18.1% | -10.2% | +5.7% | -3.2% | – | – | |
| – | – | -107.5% | – | – | – | -150.0% | – | – | – | – | – | – | |
| – | +2.6% | +20.1% | -16.7% | +26.4% | +17.7% | -3.7% | +17.7% | -10.9% | +36.8% | +2.7% | +25.9% | – | |
| – | +4.0% | -12.0% | +4.2% | -0.3% | +13.0% | +3.4% | +16.9% | -11.1% | +15.2% | +1.9% | +5.0% | – | |
| – | +3.2% | +6.6% | -9.4% | +15.7% | +16.1% | -1.3% | +17.4% | -11.0% | +29.3% | +2.4% | +19.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -6.0% | -7.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -97.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.